Agilent Technologies, Inc. (FRA:AG8)
Germany · Delayed Price · Currency is EUR | Market Cap | 42.94B +27.6% |
| Revenue (ttm) | 6.41B +8.6% |
| Net Income | 1.25B +18.0% |
| EPS | 4.41 +18.4% |
| Shares Out | n/a |
| PE Ratio | 34.30 |
| Forward PE | 25.90 |
| Dividend | 0.89 (0.59%) |
| Ex-Dividend Date | Oct 6, 2026 |
| Volume | 250 |
| Open | 149.20 |
| Previous Close | 149.25 |
| Day's Range | 149.20 - 153.40 |
| 52-Week Range | 94.18 - 155.45 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 25, 2026 |
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti... [Read more]
Financial Performance
In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.
Financial numbers in USD Financial StatementsNews
Agilent Technologies Slides: Corporate presentation
Agilent Technologies has posted slides in relation to its latest quarterly earnings report, which was published on October 8, 2026.
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratorie...
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that...
Agilent Technologies Transcript: U.S. All Stars Conference
Ignite transformation has driven growth, margin expansion, and innovation, focusing on autonomous labs and AI. China and Asia ex-China are key growth regions. LC/GC replacement cycles and service contracts support recurring revenue. Specialty CDMO targets mid-teens growth with new capacity in 2027. Disciplined capital allocation and targeted M&A support expansion.
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStation...
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of...
Agilent Announces Cash Dividend of 25.5 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on October 6...
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. Al...
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Se...
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide imaging (WSI) digital scanner, follo...
Agilent Introduces the Cary 635 FTIR Spectrometer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, high-performance Fo...
Agilent raises annual profit forecast on improving lab tools demand
Agilent Technologies raised its annual profit forecast on Wednesday, betting on improving demand for its medical tools and equipment used in lab research and drug development.
Agilent Technologies Earnings Call Transcript: Q3 2026
Q3 delivered strong revenue and EPS growth, exceeding guidance, with robust performance in pharma, advanced therapeutics, and China. FY26 guidance was raised for revenue and EPS, supported by innovation, operational execution, and strong end-market trends.
Agilent Technologies Earnings release: Q3 2026
Agilent Technologies released its Q3 2026 earnings on August 26, 2026, summarizing the period's financial results.
Agilent Technologies Slides: Q3 2026
Agilent Technologies has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on August 26, 2026.
Agilent Technologies Quarterly report: Q3 2026
Agilent Technologies has published its Q3 2026 quarterly earnings report on August 26, 2026.
Agilent Technologies Prepared remarks: Q3 2026
Agilent Technologies filed a regulatory document on August 26, 2026 disclosing important business information.
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up...
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the Eastern Institute of Technology, Ningbo has received an Agilent Research Catalyst (ARC) Award on beha...
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2026 after the stock market closes on Wednesday, Aug. 26. ...
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has received European Union (EU) certification for PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagn...
Agilent Increases Its Investment in HALO X-ray Technologies
NOTTINGHAM, England--(BUSINESS WIRE)-- #AgilentTechnologies--Multimillion dollar investment round to enable HALO to complete regulatory approval of its advanced security screening technology.
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD‑L1 IHC 28‑8 pharmDx assay as ...
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chroma...
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free ...